Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
ADAR1 Capital Management, LLC (CIK 1940272) reported $1.70B across 269 reported positions in its SEC 13F filing for 2026-03-31. Largest positions: ABVX ($160.1M, 9.43%), PTGX ($104.8M, 6.17%), ROIV ($91.0M, 5.36%), IMVT ($66.5M, 3.92%), TERN ($58.8M, 3.46%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | ABVX | ABIVAX SA | $160.1M | 9.43% | 1.4M | Added |
| 2 | PTGX | PROTAGONIST THERAPEUTICS INC | $104.8M | 6.17% | 994,119 | Trimmed |
| 3 | ROIV | ROIVANT SCIENCES LTD | $91.0M | 5.36% | 3.3M | Trimmed |
| 4 | IMVT | IMMUNOVANT INC | $66.5M | 3.92% | 2.7M | Added |
| 5 | TERN | TERNS PHARMACEUTICALS INC | $58.8M | 3.46% | 1.1M | Added |
| 6 | SPY | STATE STR SPDR S&P 500 ETF T | $49.4M | 2.91% | 75,940 | Added |
| 7 | CYTK | CYTOKINETICS INC | $41.7M | 2.45% | 632,556 | Added |
| 8 | CRNX | CRINETICS PHARMACEUTICALS IN | $41.4M | 2.44% | 1.1M | Added |
| 9 | BOXX | EA SERIES TRUST | $39.2M | 2.31% | 337,125 | Hold |
| 10 | DNLI | DENALI THERAPEUTICS INC | $35.9M | 2.12% | 1.9M | Added |
| 11 | BEAM | BEAM THERAPEUTICS INC | $34.5M | 2.03% | 1.4M | New |
| 12 | ZLAB | ZAI LAB LTD | $26.8M | 1.58% | 1.4M | Added |
| 13 | SEPN | SEPTERNA INC | $26.2M | 1.54% | 1.1M | Trimmed |
| 14 | VIR | VIR BIOTECHNOLOGY INC | $24.6M | 1.45% | 2.7M | New |
| 15 | DBVT | DBV TECHNOLOGIES S A | $21.2M | 1.25% | 1.0M | New |
| 16 | AVR | ANTERIS TECHNOLOGIES GLOBAL | $21.0M | 1.24% | 3.8M | Added |
| 17 | INSP | INSPIRE MED SYS INC | $20.9M | 1.23% | 405,197 | Added |
| 18 | SRRK | SCHOLAR ROCK HLDG CORP | $20.0M | 1.18% | 407,273 | Added |
| 19 | RYTM | RHYTHM PHARMACEUTICALS INC | $18.4M | 1.08% | 211,450 | Added |
| 20 | SYRE | SPYRE THERAPEUTICS INC | $17.1M | 1.00% | 338,323 | Added |
| 21 | CTMX | CYTOMX THERAPEUTICS INC. | $16.0M | 0.94% | 3.4M | Trimmed |
| 22 | PRTA | PROTHENA CORP PLC | $15.4M | 0.90% | 1.6M | Added |
| 23 | SNY | SANOFI SA | $15.3M | 0.90% | 316,939 | Added |
| 24 | PCVX | VAXCYTE INC | $15.1M | 0.89% | 259,137 | Trimmed |
| 25 | MNPR | MONOPAR THERAPEUTICS INC | $14.5M | 0.85% | 264,278 | Added |
Source: SEC Form 13F filings · as of 2026-03-31